Judith D. Goldberg

Judith D. Goldberg

Auto-generated profile, based on publicly available information

Judith D. Goldberg

Division of Biostatistics, Department of Population Health NYU Grossman School of Medicine New York New York USA

Research Focus & Metrics

Academic Career Length

52Years (1975-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 1984 in New England Journal of Medicine
Verified
Journal Article
Closed access
WRWilliam Ruberman
William Ruberman
EWEve Weinblatt
Eve Weinblatt
JGJudith D. Goldberg
Judith D. Goldberg
BCBanvir S. Chaudhary
Banvir S. Chaudhary
Psychosocial interviews with 2320 male survivors of acute myocardial infarction, participants in the β-Blocker Heart Attack Trial, permitted the definition of two variables strongly associated with an increased three-year mortality risk. With other important prognostic factors controlled for, the patients classified as being socially isolated and having a high degree of life stress had more than four times the risk of death of the men with low levels of both stress and isolation. An inverse association of education with mortality in this population reflected the gradient in the prevalence of the defined psychosocial characteristics. High levels of stress and social isolation were most prevalent among the least-educated men and least prevalent among the best-educated. The increase in risk associated with stress and social isolation applied both to total deaths and to sudden cardiac deaths and was noted among men with both high and low levels of ventricular ectopy during hospitalization for the acute infarction. (N Engl J Med 1984; 311:552–9.)

1 July 2015 in The Lancet Oncology
Verified
Journal Article
Closed access
EGEncouse B Golden
Encouse B Golden
ACArpit Chhabra
Arpit Chhabra
ACAbraham Chachoua
Abraham Chachoua
SASylvia Adams
Sylvia Adams
MDMartin Donach
Martin Donach
SFSilvia C Formenti
Silvia C Formenti

6 October 1977 in New England Journal of Medicine
Verified
Journal Article
Closed access
WRWilliam Ruberman
William Ruberman
EWEve Weinblatt
Eve Weinblatt
JGJudith D. Goldberg
Judith D. Goldberg
CFCharles W. Frank
Charles W. Frank
SSSam Shapiro
Sam Shapiro
To assess the role of ventricular premature beats in influencing mortality of coronary patients, 1739 men with prior myocardial infarction were monitored for ectopic activity for one hour at a standard base-line examination, and followed for mortality for periods up to four years (average, 24.4 months). Analyses of survival taking into account other important prognostic variables establish that the presence of complex premature beats (R on T, runs of 2 or more, multiform or bigeminal premature beats) in the monitoring hour is associated with a risk of sudden coronary death three times that of the men free of complex ventricular premature beats. The corresponding risk of death from any cause is twice that of men without such complex beats in the hour. These arrhythmias make an independent contribution to increased risk of death that persists over the length of this observation period. (N Engl J Med 297:750–757, 1977)

19 February 1981 in New England Journal of Medicine
Verified
Journal Article
Closed access
PBPaul D. Berk
Paul D. Berk
JGJudith D. Goldberg
Judith D. Goldberg
MSMurray N. Silverstein
Murray N. Silverstein
AWAleksander Weinfeld
Aleksander Weinfeld
PDPaul B. Donovan
Paul B. Donovan
LWLouis R. Wasserman
Louis R. Wasserman
In studies to determine the optimal treatment for polycythemia vera, 431 previously untreated patients whose disease met established diagnostic criteria were entered into a prospective, randomized controlled trial between 1967 and 1974. Three treatment regimens were used: phlebotomy alone, chlorambucil supplemented by phlebotomy, or radioactive phosphorus supplemented by phlebotomy. Despite minor differences in age and sex, the three groups were comparable in initial hematocrit, white-cell and platelet counts, and disease-related symptoms. The median duration of follow-up is now more than 6 1/2 years. As of February 15, 1980, there were no statistically significant differences in survival among the groups. However, the risk of acute leukemia in patients given chlorambucil was 2.3 times that in patients given radioactive phosphorus and 13 times that in patients treated with phlebotomy alone. The increased incidence of leukemia during chlorambucil treatment is statistically significant (P≤0.002); accordingly, the Polycythemia Vera Study Group has discontinued the use of chlorambucil in the treatment of polycythemia vera. (N Engl J Med. 1981; 304: 441–7.)

1 November 2007 in Molecular Cell
Verified
Journal Article
Closed access
SBSteve Braunstein
Steve Braunstein
KKKsenia Karpisheva
Ksenia Karpisheva
CPCarolina Pola
Carolina Pola
JGJudith Goldberg
Judith Goldberg
THTsivia Hochman
Tsivia Hochman
RSRobert J. Schneider
Robert J. Schneider

1 August 1981 in Circulation
Verified
Journal Article
Closed access
PDF file
WRW Ruberman
W Ruberman
EWE Weinblatt
E Weinblatt
JGJ D Goldberg
J D Goldberg
CFC W Frank
C W Frank
BCB S Chaudhary
B S Chaudhary
SSS Shapiro
S Shapiro
Among 1739 male survivors of myocardial infarction, mortality over 5 years was examined in relation to presence of complex ventricular premature complexes (R on T, runs of two or more, multiform or bigeminal complexes) identified during 1 hour of monitoring. Such arrhythmia was associated with excess risk of death over the entire period. Men with R on T or runs during the hour show a 5-year sudden coronary death rate of 25%, compared with 6% of men free of premature complexes. Men with complex ventricular premature complexes are also at relatively higher risk for nonsudden cardiac death than the other men (5-year mortality 15% and 7%, respectively), but no additional disadvantage was associated with the presence of R on T or runs. Multivariate survival analyses, controlling simultaneously for other important clinical factors, identify complex ventricular premature complexes as the strongest influence on risk of sudden coronary death and congestive heart failure as the strongest influence on risk of other cardiac death.